Owen Thomas

ORCID: 0000-0003-2877-3075
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neurofibromatosis and Schwannoma Cases
  • Meningioma and schwannoma management
  • Bone Tumor Diagnosis and Treatments
  • Parallel Computing and Optimization Techniques
  • Distributed and Parallel Computing Systems
  • Medical Image Segmentation Techniques
  • Cerebrovascular and Carotid Artery Diseases
  • Glioma Diagnosis and Treatment
  • Brain Tumor Detection and Classification
  • Advanced MRI Techniques and Applications
  • Advanced Neural Network Applications
  • Radiomics and Machine Learning in Medical Imaging
  • Intracranial Aneurysms: Treatment and Complications
  • MRI in cancer diagnosis
  • Advanced Data Storage Technologies
  • Vascular Malformations Diagnosis and Treatment
  • Visual perception and processing mechanisms
  • Functional Brain Connectivity Studies
  • Patient-Provider Communication in Healthcare
  • Simulation Techniques and Applications
  • Chromatin Remodeling and Cancer
  • Cardiovascular Health and Disease Prevention
  • Color Science and Applications
  • Lanthanide and Transition Metal Complexes
  • Spinal Dysraphism and Malformations

Akershus University Hospital
2021-2024

Salford Royal NHS Foundation Trust
2015-2024

Manchester Academic Health Science Centre
2017-2024

Salford Royal Hospital
2020-2024

Countess of Chester Hospital NHS Foundation Trust
2017

University of Cambridge
2012-2015

Cambridge University Hospitals NHS Foundation Trust
2012-2014

Addenbrooke's Hospital
2013

Data61
2010

John Radcliffe Hospital
2008

The full extent of the brain's ability to compensate for damage or changed experience is yet be established. One question particularly important evaluating and understanding rehabilitation following brain whether recovery involves new aberrant neural connections any change in function due functional recruitment existing pathways, both. Blindsight, a condition which subjects with complete destruction part striate cortex (V1) retain extensive visual capacities within clinically blind field, an...

10.1093/brain/awn063 article EN Brain 2008-05-09

Objectives Schwannomatosis is a dominantly inherited condition predisposing to schwannomas of mainly spinal and peripheral nerves with some diagnostic overlap neurofibromatosis-2 (NF2), but the underlying epidemiology poorly understood. We present birth incidence prevalence allowing for NF2. Methods NF2 cases were ascertained from Manchester region England (population=4.8 million) across UK. Point calculated regional statistics. Genetic analysis was also performed on , LZTR1 SMARCB1 blood...

10.1136/jnnp-2018-318538 article EN Journal of Neurology Neurosurgery & Psychiatry 2018-06-16

To evaluate the incidence of mosaicism in de novo neurofibromatosis 2 (NF2).Patients fulfilling NF2 criteria, but with no known affected family member from a previous generation (n = 1055), were tested for variants lymphocyte DNA and where available tumor DNA. The proportion individuals proven or presumed mosaic variant was assessed allele frequencies identified evaluated using next-generation sequencing.The rate proven/presumed 232/1055 (22.0%). However, nonmosaic heterozygous pathogenic...

10.1038/s41436-019-0598-7 article EN publisher-specific-oa Genetics in Medicine 2019-07-04

Neurofibromatosis 1 (NF1) is a monogenic model for syndromic autism. Statins rescue the social and cognitive phenotype in animal knockout models, but translational trials with subjects > 8 years using cognition/behaviour outcomes have shown mixed results. This trial breaks new ground by studying statin effects first time younger children NF1 co-morbid autism multiparametric imaging outcomes. A single-site triple-blind RCT of simvastatin vs. placebo was done. Assessment (baseline 12-week...

10.1186/s13229-018-0190-z article EN cc-by Molecular Autism 2018-02-22
D. Gareth Evans Dorothy Halliday Rupert Obholzer Shazia Afridi Claire Forde and 95 more Scott Rutherford Charlotte Hammerbeck-Ward Simon Lloyd Simon Freeman Omar Pathmanaban Owen Thomas Roger Laitt Stavros Stivaros John‐Paul Kilday Grace Vassallo Catherine McBain Timothy Lavin Chay Paterson Gillian Whitfield Martin G. McCabe Patrick Axon Jane Halliday Samuel MacKeith Allyson Parry Patrick Axon Juliette Buttimore James R. Tysome Neil Donnelly Daniele Borsetto James Whitworth Anke Hensiek R. Jena Mathew R. Guilfoyle Richard Mannion James Nicholson Brinda Muthusamy Amy Taylor Richard D. Price Karine Edme Nicola Gamazo Zebunnisa Vanat Daniel Scoffings Josh Scott Sarah Jefferies Richard Knight Tamara Lamb Yu Chuen Tam K. Foweraker Fiona Harris Paul Sanghera Sara Meade Richard Irving Peter Monksfield Nicola Ragge Melanie Murrell Julian Barwell Martin English Rikin Trivedi Shazia Afridi Rosalie E. Ferner Rupert Obholzer Victoria Williams Chris Hammond Karine Lascelles Chris Skilbeck Adam Shaw Angela Swampillai Suki Thomson Nicholas J. Thomas Eleni Maratos Sinan Barazi Rebecca Mullin Susie M.D. Henley Natalie Smith Lal Carlton-Jones Alison Baker Mandy Myers Terry Nunn Charles Nduka Raji Anup Chris Duff Simon Freeman Nicola Jarvis Ian Kamaly-Asl Andrew T. King Mark Kellett John‐Paul Kilday Simon Lloyd Catherine McBain Roger Laitt Martin O’Driscoll Martin G. McCabe Mary Perry Scott Rutherford K. Henshaw Stavros Stivaros Owen Thomas Grace Vassallo Charlotte Hammerbeck-Ward Omar Pathmanaban

Abstract Background Radiation treatment of benign tumors in tumor predisposition syndromes is controversial, but short-term studies from centers suggest safety despite apparent radiation-associated malignancy being reported. We determined whether radiation NF2-related schwannomatosis patients associated with increased rates subsequent (M)/malignant progression (MP). Methods All UK NF2 were eligible if they had a clinical/molecular diagnosis. Cases treated for tumors. Controls matched...

10.1093/noajnl/vdad025 article EN cc-by Neuro-Oncology Advances 2023-01-01

Objectives New diagnostic criteria for NF2-related schwannomatosis (NF2) were published in 2022. An updated UK prevalence was generated accordance with these, an emphasis on the rate of de novo NF2 (a 50% frequency is widely quoted genetic counselling). The distribution variant types among and familial cases also assessed. Methods National database identifies patients meeting from a highly ascertained population cared by England’s specialised service. Diagnostic assessed 1 February 2023....

10.1136/jmg-2024-110065 article EN Journal of Medical Genetics 2024-06-26

The relationship of proliferation to the developmental sequence associated with bone cell differentiation was examined in primary osteoblast cultures derived from fetal rat and embryonic chick calvaria. A reciprocal functional exists between decline proliferative activity which occurs during initial stages induction genes encoding phenotype proteins matrix maturation mineralization. This is supported by 1) a temporal events there an enhanced expression alkaline phosphatase (AP) osteopontin...

10.3109/03008208909023869 article EN Connective Tissue Research 1989-01-01

Loss of shape recognition in visual-form agnosia occurs without equivalent losses the use vision to guide actions, providing support for hypothesis two visual systems (for “perception” and “action”). The human individual DF received a toxic exposure carbon monoxide some years ago, which resulted persisting that has been extensively characterized at behavioral level. We conducted detailed high-resolution MRI study DF9s cortex, combining structural functional measurements. present first...

10.1523/jneurosci.4853-12.2013 article EN Journal of Neuroscience 2013-07-31

<h3>BACKGROUND AND PURPOSE:</h3> Dilated perivascular spaces have been shown to be a specific biomarker of cerebral small-vessel disease in young patients with dementia. Our aim was examine the discriminative power dilated as biomarkers very elderly population <h3>MATERIALS METHODS:</h3> We studied healthy volunteers (<i>n</i> = 65; mean age, 78 ± 5.6 years) and subjects vascular dementia 39; 76.9 7.7 Alzheimer 47; 74.1 8.5 years). compared white matter hyperintensity 2 semiquantitative...

10.3174/ajnr.a4237 article EN cc-by American Journal of Neuroradiology 2015-02-19

Abstract Background Limited data exist on the disease course of neurofibromatosis type 2 (NF2) to guide clinical trial design. Methods A prospective database patients meeting NF2 diagnostic criteria, reviewed between 1990 and 2020, was evaluated. Follow-up first vestibular schwannoma (VS) intervention death assessed by univariate analysis stratified age at onset, era referred, inheritance type. Interventions for NF2-related tumors were assessed. Cox regression performed determine...

10.1093/neuonc/noaa284 article EN Neuro-Oncology 2020-12-16

The impact of calcification on the carotid atherosclerotic plaque vulnerability remains controversial and unclear. This study assesses critical mechanical conditions induced by calcium at lumen surface, i.e., juxtaluminal (JLCa), within human plaque. Eleven patients with evidence JLCa were included for analysis. geometry was reconstructed based computed tomography magnetic resonance images 3-D fluid-structure interaction simulation used presence increased local stresses compared to when...

10.1109/tbme.2013.2275078 article EN IEEE Transactions on Biomedical Engineering 2013-07-31

The published literature suggests that malignant peripheral nerve sheath tumors (MPNST) occur at increased frequency in neurofibromatosis type 2 (NF2). A recent review based on incidence data North America showed 1 per 1000 cerebellopontine angle were malignant.To determine whether MPNST occurred spontaneously NF2 by reviewing our database.The prospective database consists of 1253 patients with NF2. One thousand and nine are known to be alive last follow-up. presence laterality/pathology...

10.1093/neuros/nyx368 article EN Neurosurgery 2017-06-25

Objectives/Hypothesis Unilateral vestibular schwannoma (VS) occurs with a lifetime risk of around 1 in 1,000 and is due to inactivation the NF2 gene, either somatically or from constitutional mutation. It has been postulated that familial occurrence unilateral VS more frequently than by chance, but no causal mechanism confirmed. Study Design Retrospective database analysis. Methods The likelihood chance VS, occurring context neurofibromatosis type 2 (NF2), was assessed using national UK...

10.1002/lary.27554 article EN cc-by-nc The Laryngoscope 2018-10-16

Background Hospitals should adopt multiple methods to monitor incidents for a comprehensive review of the types that occur. Contrary traditional incident reporting systems, Green Cross (GC) method is simple visual recognise based on teamwork and safety briefings. Its longitudinal effect patient culture has not been previously assessed. This study aimed explore whether implementation GC in postanaesthesia care unit changed nurses’ perceptions different factors associated with over 4 years....

10.1136/bmjoq-2024-002964 article EN cc-by-nc-nd BMJ Open Quality 2024-10-01

The Manchester criteria for neurofibromatosis type 2 (NF2) include a range of tumors, and gliomas were incorporated in the original description. are now widely accepted to be predominantly spinal cord ependymomas.To determine whether these any cases malignant glioma (WHO grade III IV) through database review.The prospective consists 1253 patients with NF2. 1009 known alive at last follow-up.There was single case glioblastoma multiforme (GBM; World Health Organization series no WHO gliomas....

10.1093/neuros/nyx374 article EN Neurosurgery 2017-06-25

Objective To evaluate the effect of a specific communication training for neurologists on how to provide complex information about treatment options patients with multiple sclerosis (MS). Design Single-centre, single-blind, randomised controlled trial. Setting One university hospital in Norway. Participants Thirty-four early-stage MS. Intervention A 3-hour MS escalation therapy. Main outcome measures Patient recall rate, measured reliable counting system provided and recalled drugs....

10.1136/bmjopen-2021-049817 article EN cc-by-nc BMJ Open 2022-03-01
Coming Soon ...